Library / learning-module
Understanding pharmaceutical biotechnology
Audience: patients-public, students-learners ยท Review state: published
Medicines made by living cells
Pharmaceutical biotechnology produces medicines using living systems rather than chemical synthesis: proteins, antibodies, vaccines, and cell and gene therapies. Regulators describe biologics as products derived from living sources, including sugars, proteins and nucleic acids, or complex combinations of them.
Insulin made by engineered bacteria was the founding example in the 1980s; the field now supplies a large share of new medicines, including many cancer and autoimmune treatments.
How biologics differ from chemical drugs
A chemical drug is a small, precisely defined molecule that can be synthesized identically batch after batch. A biologic is a large, complex protein made by cells, where the manufacturing process shapes the product itself: change the cells or conditions and the product subtly changes.
This is why biologics cannot be copied exactly. Their follow-on versions, biosimilars, are highly similar rather than identical, and earn approval by demonstrating no meaningful clinical difference from the original.
The manufacturing reality
Production runs living cell cultures in bioreactors, then purifies the product through cascades of filtration and chromatography, all under conditions controlling contamination and consistency. The facility is part of the product: regulators inspect manufacturing as closely as the molecule.
Cold chains matter because proteins denature with heat and freezing, which is why many biologics travel refrigerated from factory to bedside.
What patients should know
Biologics are given by injection or infusion because the gut would digest them, and they can provoke immune reactions because the body may treat the protein as foreign. Storage instructions are not optional.
Biosimilars offer the same treatment at lower cost as patents expire; regulators approve them only after analytical and clinical comparison, and prescribers can explain whether one suits a specific situation.
Limitations
Educational overview of pharmaceutical biotechnology, not an assessment of any specific product and not medical advice.